講師資料
Talks：
Co-morbid insomnia and sleep apnea (COMISA): Recent research from an emerging field
Name：
Dr. Alexander Sweetman
Position：
Senior Program Manager
Affiliation：
1. Australasian Sleep Association
2. Flinders University
Email：
Photo：
Research Interests：
I am interested in the co-morbidity of insomnia and obstructive sleep apnea (COMISA), treating insomnia with Cognitive Behavioural Therapy for insomnia (CBTi), and implementing evidence-based management approaches for sleep disorders throughout the health system.
Selected Publications：
1. Sweetman A, Lack L, … McEvoy D. (2016). Developing a Successful Treatment for Co-morbid Insomnia and Sleep Apnea. Sleep Medicine Reviews. https://doi.org/10.1016/j.smrv.2016.04.004.
2. Sweetman A, Lack L, … McEvoy D. (2019) Cognitive and behavioral therapy for insomnia increases the use of continuous positive airway pressure therapy in obstructive sleep apnea patients with co-morbid insomnia: A randomized clinical trial. Sleep. 42(12). https://doi.org/10.1093/sleep/zsz178.
3. Sweetman A, Lack L, Bastien C. (2019) Co-morbid insomnia and sleep apnea (COMISA): Prevalence, consequences, methodological considerations, and recent randomized controlled trials. Brain Sciences; November 2019, 9(12), 371. https://doi.org/10.3390/brainsci9120371.
4. Sweetman A, Farrell S, Wallace D, Crawford M. (2023). The effect of cognitive behavioural therapy for insomnia in people with co-morbid insomnia and sleep apnoea: A systematic review and meta-analysis. J Sleep Res. https://doi.org/10.1111/jsr.13847.
5. Sweetman A, Reynolds C, … Richardson C. (2023). Effect of high-risk sleep apnoea on treatment-response to a tailored digital cognitive behavioural therapy for insomnia: A quasi-experimental trial. Frontiers in Sleep. Submitted December, 2023. https://doi.org/10.3389/frsle.2024.1355468.
Abstract：
Insomnia and Obstructive Sleep Apnea (OSA) are the two most prevalent sleep disorders and frequently co-occur. Insomnia and OSA have historically been viewed as two distinct sleep disorders with separate risk factors, presenting symptoms, diagnostic pathways, treatment options, and specialist care providers. However, research now indicates that 30-40% of people with insomnia have co-morbid OSA, and 30-50% of people with OSA have co-morbid insomnia. People with Co-Morbid Insomnia and Sleep Apnea (COMISA) experience worse sleep, daytime function, mental health, physical health, quality of life and longevity, compared to people with neither sleep disorder, and often compared to people with insomnia-alone and OSA-alone.

Effective treatment approaches exist for each disorder alone. However, few studies have investigated the effectiveness, suitability, uptake and access to these treatments in people with COMISA.

In this presentation, Dr Alexander Sweetman, a Senior Program Manager at the Australasian Sleep Association and academic researcher at Flinders University, will provide an overview of the emergence of the COMISA field, impacts of COMISA on sleep, health, daytime function, and longevity, recent advances in the discovery of evidence-based treatment approaches for people with COMISA, implementation of COMISA management approaches throughout the health system, and future directions for the field.
2024年會：
10/13 09:00 Keynote lecture 1: Co-morbid insomnia and sleep apnea (COMISA): Recent research from an emerging field [會議室2]